{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:21:54Z","timestamp":1766546514518,"version":"3.48.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127563","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T02:05:11Z","timestamp":1754359511000},"page":"127563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses"],"prefix":"10.1016","volume":"62","author":[{"given":"Pierre","family":"Authi\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Souque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Moncoq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Noirat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Ciret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryline","family":"Bourgine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Guinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laleh","family":"Majlessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Charneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill","family":"Nemirov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127563_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2020.01.015","article-title":"Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development","volume":"543","author":"Pielnaa","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127563_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008640","article-title":"Leveraging multiple data types to estimate the size of the Zika epidemic in the Americas","volume":"14","author":"Moore","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.127563_bb0015","first-page":"10","article-title":"Current Advances in Zika Vaccine Development","author":"Wang","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127563_bb0020","first-page":"14","article-title":"The present and future of yellow fever vaccines","author":"Hansen","year":"2021","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.vaccine.2025.127563_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","article-title":"Yellow fever virus: knowledge gaps impeding the fight against an old foe","volume":"26","author":"Douam","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0030","first-page":"56","article-title":"Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat","author":"Waggoner","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0035","first-page":"12","article-title":"Re-emergence of yellow fever in Brazil during 2016-2019: challenges, lessons learned, and perspectives","author":"de Oliveira","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127563_bb0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8160","article-title":"Assessing the global threat from Zika virus","volume":"353","author":"Lessler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127563_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127563_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coviro.2020.08.006","article-title":"Protective and enhancing interactions among dengue viruses 1-4 and Zika virus","volume":"43","author":"Katzelnick","year":"2020","journal-title":"Curr Opin Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127563_bb0060","doi-asserted-by":"crossref","first-page":"16164","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"1","author":"Chan","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0065","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41467-024-45806-x","article-title":"Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection","volume":"15","author":"Santos-Peral","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127563_bb0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination","volume":"4","author":"Bradt","year":"2019","journal-title":"NPJ vaccines"},{"key":"10.1016\/j.vaccine.2025.127563_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15020385","article-title":"Immune responses to dengue and Zika viruses-guidance for T cell vaccine development","volume":"15","author":"Roth","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2025.127563_bb0080","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3389\/fimmu.2019.02125","article-title":"Human T cell response to dengue virus infection","volume":"10","author":"Tian","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0085","first-page":"8","article-title":"Protective to a T: The Role of T Cells during Zika Virus Infection","author":"Pardy","year":"2019","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127563_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0095","first-page":"10","article-title":"Improved immune responses against Zika virus after sequential dengue and Zika virus infection in humans","author":"Delgado","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127563_bb0100","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127563_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.36","article-title":"Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8(+) T cells","volume":"2","author":"Wen","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0110","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0115","first-page":"15","article-title":"Lentiviral vectors as a vaccine platform against infectious diseases","author":"Nemirov","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2025.127563_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1208041","article-title":"Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses","volume":"14","author":"Nemirov","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0125","unstructured":"Consensus Maker - HIV sequence database [Internet]. Los Alamos National Laboratory [cited 2025 Jul 25]. Available from: https:\/\/www.hiv.lanl.gov\/content\/sequence\/CONSENSUS\/consensus.html."},{"key":"10.1016\/j.vaccine.2025.127563_bb0130","unstructured":"Immune Epitope Database (IEDB) [Internet] [cited 2025 Jul 25]. Available from: http:\/\/www.iedb.org."},{"key":"10.1016\/j.vaccine.2025.127563_bb0135","unstructured":"DTU Health Tech: Department of Health Technology [Internet]. Bioinformatic Services [cited 2025 Jul 25]. Available from: https:\/\/services.healthtech.dtu.dk."},{"key":"10.1016\/j.vaccine.2025.127563_bb0140","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.4049\/jimmunol.1302101","article-title":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity","volume":"191","author":"Paul","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010038","article-title":"Recombinant Zika NS1 protein secreted from Vero cells is efficient for inducing production of immune serum directed against NS1 dimer","volume":"19","author":"Viranaicken","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2025.127563_bb0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s42003-021-02251-6","article-title":"Lentiviral vector induces high-quality memory T cells via dendritic cells transduction","volume":"4","author":"Ku","year":"2021","journal-title":"Commun biol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0092-8674(00)80828-4","article-title":"HIV-1 genome nuclear import is mediated by a central DNA flap","volume":"101","author":"Zennou","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2025.127563_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111142","article-title":"A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4(+) T cell immunity","volume":"40","author":"Lopez","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2025.127563_bb0165","article-title":"A simple flow cytometry based assay to determine in vitro antibody dependent enhancement of dengue virus using Zika virus convalescent serum","volume":"134","author":"Valiant","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2025.127563_bb0170","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, yap state, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127563_bb0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-0934(03)00129-0","article-title":"Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay","volume":"110","author":"Bae","year":"2003","journal-title":"J Virol Methods"},{"year":"2025","series-title":"GraphPad software. Version 9.5.0 for windows ed","author":"GraphPad Prism","key":"10.1016\/j.vaccine.2025.127563_bb0180"},{"key":"10.1016\/j.vaccine.2025.127563_bb0185","first-page":"8","article-title":"Genome-wide diversity of Zika virus: exploring spatio-temporal dynamics to guide a new nomenclature proposal","author":"Seabra","year":"2022","journal-title":"Virus evolution"},{"key":"10.1016\/j.vaccine.2025.127563_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.12.010","article-title":"Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy","volume":"115","author":"Beasley","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2025.127563_bb0195","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1099\/vir.0.000075","article-title":"Spectrum of disease outcomes in mice infected with YFV-17D","volume":"96","author":"Erickson","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0200","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/vaccines9060622","article-title":"Flavivirus NS1 and its potential in vaccine development","volume":"9","author":"Carpio","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127563_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01034-19","article-title":"Genetic diversity of collaborative cross mice controls viral replication, clinical severity, and brain pathology induced by Zika virus infection, independently of Oas1b","volume":"94","author":"Manet","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0210","first-page":"6","article-title":"Fast tracks and roadblocks for Zika vaccines","author":"Ghaffar","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127563_bb0215","first-page":"6","article-title":"CD8(+) T cells mediate protection against Zika virus induced by an NS3-based vaccine","author":"Elong Ngono","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2025.127563_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109107","article-title":"A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage","volume":"35","author":"Gambino","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2025.127563_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune response to dengue and Zika","volume":"36","author":"Ngono","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2025.127563_bb0230","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","article-title":"Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b","volume":"71","author":"Putnak","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0235","first-page":"9","article-title":"T cell-mediated immunity towards yellow fever virus and useful animal models","author":"Watson","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127563_bb0240","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41385-022-00566-z","article-title":"A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity","volume":"15","author":"Anna","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2025.127563_bb0245","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.ymthe.2020.05.016","article-title":"A single dose of NILV-based vaccine provides rapid and durable protection against Zika virus","volume":"28","author":"Ku","year":"2020","journal-title":"Mol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:20:08Z","timestamp":1766546408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25008606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":49,"alternative-id":["S0264410X25008606"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127563","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127563"}}